US 4,278,793 A · Cephem derivative

Abstract

Cephem derivatives of the general formula ##STR1## in which the R.sub.2 O group is in the syn-position, a process for their manufacture and pharmaceutical formulations which are active against bacterial infections and contain these compounds.

Claims1

Dependent claims

7-.beta.-[2-(2-a mino-thiazol-4-yl)-2-syn-methoximino-acetamido]-3-(5-carboxymethyl-4-methyl -1,3-thiazol-2yl-thiomethyl)-ceph-3-em-4-carboxylic acid.

Dependencies are inferred from the claim text.

Facts

Application

06/170,839Filed 21 Jul 1980 · continuation

Priority

DE 27148802 Apr 1977

Granted

14 Jul 1981

Term ends

Not estimatedThe source records don’t support an estimate.

Classification18 codes

C07D 277/20
Not condensed with other rings: having two or three double bonds between ring members or between ring members and non-ring members
A61K 31/435
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having six-membered rings with one nitrogen as the only ring hetero atom
A61K 31/505
Having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines: pyrimidines; Hydrogenated…
A61K 31/535
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having six-membered rings with at least one nitrogen and one oxygen as the…

Cephem derivative

Life of this patent

Abstract

Claims1

Cephem derivative

Life of this patent

Abstract

Claims1